← FDA DRUG APPROVALS
FDA NDA · NDA018954
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor: ABBOTT
APPLICATION
NDA018954
TYPE
NDA
ORIGINAL APPROVAL
1985-07-09
LATEST ACTION
1985-07-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
LIDOCAINE HYDROCHLORIDE 200MG/100ML · INJECTABLE · INJECTION
Approval history
1985-07-09Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.